Matrix Degradation in Human Immunodeficiency Virus Type 1-Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study

Clinical Infectious Diseases

Volumn 65, Issue 1, 2017, Pages 121-132

  Walker, Naomi F ^a,b,c   Wilkinson, Katalin A ^a,d   Meintjes, Graeme ^a   Tezera, Liku B ^e   Goliath, Rene ^a   Peyper, Janique M ^a,f   Tadokera, Rebecca ^a,g   Opondo, Charles ^c   Coussens, Anna K ^a   Wilkinson, Robert J ^a,d,h   Friedland, Jon S ^b   Elkington, Paul T ^b,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f Department of Integrative Biomedical Sciences ^*  (South Africa)

^g HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

HIV 1; immune reconstitution inflammatory syndrome; matrix metalloproteinase; procollagen III N terminal propeptide; tuberculosis

Indexed keywords

C REACTIVE PROTEIN; COLLAGENASE; DOXYCYCLINE; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; LIPOARABINOMANNAN; MATRILYSIN; MATRIX METALLOPROTEINASE; MYCOBACTERIUM ANTIGEN; NEUTROPHIL COLLAGENASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; STROMELYSIN; STROMELYSIN 2; MMP8 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FEMALE; GRANULOMA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IN VITRO STUDY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SOUTH AFRICA; THORAX RADIOGRAPHY; TUBERCULOSIS; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; YOUNG ADULT;

ADULT; COLLAGENASES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MATRIX METALLOPROTEINASE 8; PEPTIDE FRAGMENTS; PROCOLLAGEN; PROSPECTIVE STUDIES; SOUTH AFRICA; TUBERCULOSIS; YOUNG ADULT;

EID: 85021809699     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix231     Document Type: Article

References (34)

1. Kwan CK, Ernst JD. HIV and tuberculosis: A deadly human syndemic. Clin Microbiol Rev 2011; 24:351-76.
2. Walker NF, Scriven J, Meintjes G, Wilkinson RJ. Immune reconstitution inflammatory syndrome in HIV-infected patients. HIV AIDS (Auckl) 2015; 7:49-64.
3. Meintjes G, Lawn SD, Scano F, et al; International Network for the Study of HIVassociated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: Case definitions for use in resource-limited settings. Lancet Infect Dis 2008; 8:516-23.
4. Elkington PT, Friedland JS. Permutations of time and place in tuberculosis. Lancet Infect Dis 2015; 15:1357-60.
5. Walker NF, Meintjes G, Wilkinson RJ. HIV-1 and the immune response to TB. Future Virol 2013; 8:57-80.
6. Lai RP, Meintjes G, Wilkinson KA, et al. HIV-tuberculosis-associated immune reconstitution inflammatory syndrome is characterized by Toll-like receptor and inflammasome signalling. Nat Commun 2015; 6:8451.
7. Tadokera R, Meintjes G, Skolimowska KH, et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 2011; 37:1248-59.
8. Ravimohan S, Tamuhla N, Steenhoff AP, et al. Immunological profiling of tuberculosis-A ssociated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: A prospective observational cohort study. Lancet Infect Dis 2015; 15:429-38.
9. Andrade BB, Singh A, Narendran G, et al. Mycobacterial antigen driven activation of CD14++CD16-monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndrome. PLoS Pathog 2014; 10:e1004433.
10. Elkington P, Shiomi T, Breen R, et al. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J Clin Invest 2011; 121:1827-33.
11. Seddon J, Kasprowicz V, Walker NF, et al. Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis. J Infect Dis 2013; 208:1571-9.
12. Walker NF, Clark SO, Oni T, et al. Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases. Am J Respir Crit Care Med 2012; 185:989-97.
13. Tadokera R, Meintjes GA, Wilkinson KA, et al. Matrix metalloproteinases and tissue damage in HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur J Immunol 2014; 44:127-36.
14. Workman VL, Tezera LB, Elkington PT, Jayasinghe SN. Controlled generation of microspheres incorporating extracellular matrix fibrils for three-dimensional cell culture. Adv Funct Mater 2014; 24:2648-57.
15. Tezera LB, Bielecka MK, Chancellor A, et al. Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model. Elife 2017; 6. pii:e21283.
16. Wallis RS, Maeurer M, Mwaba P, et al. Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, biomarkers. Lancet Infect Dis 2016; 16:e34-46.
17. Naidoo K, Naidoo K, Padayatchi N, Abdool Karim Q. HIV-associated tuberculosis. Clin Dev Immunol 2011; 2011.
18. Lienhardt C, Lonnroth K, Menzies D, et al. Translational research for tuberculosis elimination: Priorities, challenges, actions. PLoS Med 2016; 13:e1001965.
19. Marais S, Wilkinson KA, Lesosky M, et al. Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2014; 59:1638-47.
20. Ravimohan S, Tamuhla N, Kung SJ, et al. Matrix metalloproteinases in tuberculosis-immune reconstitution inflammatory syndrome and impaired lung function among advanced HIV/TB co-infected patients initiating antiretroviral therapy. EBioMedicine 2016; 3:100-7.
21. Ong CW, Elkington PT, Brilha S, et al. Neutrophil-derived MMP-8 drives AMPKdependent matrix destruction in human pulmonary tuberculosis. PLoS Pathog 2015; 11:e1004917.
22. Lowe DM, Bandara AK, Packe GE, et al. Neutrophilia independently predicts death in tuberculosis. Eur Respir J 2013; 42:1752-7.
23. Wilkinson KA, Walker NF, Meintjes G, et al. Cytotoxic mediators in paradoxical HIV-tuberculosis immune reconstitution inflammatory syndrome. J Immunol 2015; 194:1748-54.
24. Musselwhite LW, Andrade BB, Ellenberg SS, et al. Vitamin D, D-dimer, interferon, sCD14 levels are independently associated with immune reconstitution inflammatory syndrome: A prospective, international study. EBioMedicine 2016; 4:115-23.
25. Boulware DR, Hullsiek KH, Puronen CE, et al; INSIGHT Study Group. Higher levels of CRP, D-dimer, IL-6, hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis 2011; 203:1637-46.
26. Marais S, Meintjes G, Pepper DJ, et al. Frequency, severity, prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013; 56:450-60.
27. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010; 24:2381-90.
28. Green JA, Tran CT, Farrar JJ, et al. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS One 2009; 4:e7277.
29. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J Immunol 1991; 146:2724-9.
30. Elkington PT, Nuttall RK, Boyle JJ, et al. Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am J Respir Crit Care Med 2005; 172:1596-604.
31. Al Shammari B, Shiomi T, Tezera L, et al. The extracellular matrix regulates granuloma necrosis in tuberculosis. J Infect Dis 2015; 212:463-73.
32. Golub LM, McNamara TF, Ryan ME, et al. Adjunctive treatment with subantimicrobial doses of doxycycline: Effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001; 28:146-56.
33. Sathyamoorthy T, Sandhu G, Tezera LB, et al. Gender-dependent differences in plasma matrix metalloproteinase-8 elevated in pulmonary tuberculosis. PLoS One 2015; 10:e0117605.
34. Kaner RJ, Santiago F, Crystal RG. Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1(+) smokers with early emphysema. J Leukoc Biol 2009; 86:913-22.